493280 — IMBiologics Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩638bn
- KR₩566bn
- KR₩12bn
Annual cashflow statement for IMBiologics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -48,537 | -11,884 | 877 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 40,353 | 26,608 | 312 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -1,757 | 1,668 | -1,335 |
| Change in Other Assets | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -9,528 | 16,875 | 393 |
| Capital Expenditures | -95 | -336 | -502 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -11,015 | -15,207 | -35,815 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -11,110 | -15,543 | -36,318 |
| Financing Cash Flow Items | 89.8 | 11.6 | 75.8 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 19,954 | -128 | 42,167 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -684 | 1,452 | 6,241 |